Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients
Résumé
Background Severe COVID-19 is associated with a high circulating level of calprotectin, the S100A8/S100A9 alarmin heterodimer. Baseline calprotectin amount measured in peripheral blood at diagnosis correlates with disease severity. The optimal use of this biomarker along COVID-19 course remains to be delineated.
Origine | Accord explicite pour ce dépôt |
---|---|
licence |